News

The vaccine will only be available to those at high risk from Covid—excluding those who may need it to protect a relative or ...
The gravity of these decisions calls for a degree of humility on the part of an FDA leader. And that’s the rub with Vinay ...
The US Food and Drug Administration (FDA) has approved Novavax's Covid-19 vaccine, Nuvaxovid, but only for limited use in ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...
Novavax (NVAX) stock in focus as the U.S. FDA approves its COVID-19 vaccine Nuvaxovid for high-risk groups in the U.S. Read ...
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with ...
The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until ...
Covid-19 vaccines, first cleared by the US Food and Drug Administration in late 2020, have been updated each year in a system similar to that used for flu vaccines, so they can better target ...
The U.S. Food and Drug Administration (FDA) is planning to require all new vaccines to undergo placebo-controlled trials before approval, multiple news outlets reported late Wednesday, citing the ...